Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Protocol ID
ACNS1821
Disease (Sub Disease)
Diffuse Intrinsic Pontine Glioma
Diagnosis Stage
Newly diagnosed
Sponsor
National Cancer Institute (NCI)
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
12 Months to 21 Years
International registry ID's
NCT05099003
Back to Registry
Study Title A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Protocol ID ACNS1821
Disease (Sub Disease) Diffuse Intrinsic Pontine Glioma
Diagnosis Stage Newly diagnosed
Sponsor National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT05099003
Trial Status Preparing to Open
Study Type Treatment
Phase Phase 1/2
Age Eligibility 12 Months to 21 Years
International registry ID's NCT05099003